Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 11/08/23 08:00:32 on US and Canada Markets.
Phase 1b Study of NXP800 in Patients with Platinum Resistant, ARID1a-Mutated Ovarian Carcinoma is Ongoing Initiated the Phase 1a Dose Escalation Study of NXP900 in Patients with Advanced Solid Tumors NXP800 Granted Orphan Drug Designation for the Treatment of Cholangiocarc...
The upcoming offshore campaign is the latest in The Metals Company subsidiary NORI’s Environmental and Social Impact Assessment (ESIA) to characterise the potential impacts of proposed polymetallic nodule collection operations. Scientists from several leading marine research institutio...
- Continuing to open CONNECT1-EDO51 trial sites in Canada - - Opening of FREEDOM-DM1 trial sites underway in the U.S. and Canada - - Ended third quarter 2023 with cash and cash equivalents of $129.5 million; cash runway expected into 2025 - BOSTON, Nov. 08, 2023 (G...
Recruitment of a panel of leading KOL surgeons who believe Nociscan can improve the diagnosis and treatment of discogenic low back pain is a critical step to establishing Nociscan as standard of care. Aclarion’s KOL panel represents spine surgeons at some of the largest and most influe...
Recruitment of a panel of leading KOL surgeons who believe Nociscan can improve the diagnosis and treatment of discogenic low back pain is a critical step to establishing Nociscan as standard of care. Aclarion’s KOL panel represents spine surgeons at some of the largest and most influe...
NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- LifeMD (NASDAQ: LFMD), a leading direct-to-patient telehealth company, announced today it's been ranked 166 on the Deloitte Technology Fast 500 ™, a prestigious ranking of the fastest-growing technology, media, telecommunications,...
IceCure Medical to Report Third Quarter 2023 Financial & Operational Results on November 15, 2023 IceCure Medical to Report Third Quarter 2023 Financial & Operational Results on November 15, 2023 PR Newswire CAESAREA, Israel , Nov. 8, 2023 /PRNewswire...
Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update PR Newswire PRECISION1 trial of nab-sirolimus in solid tumors with TSC1 or TSC2 inactivating alterations on track for presentation of early interim analysis by mid-Decembe...
SEATTLE, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases and a visio...
SAN DIEGO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancer, today announced that management will participate in ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
2.6%Change Percent:
Canopy Growth Corporation Company Name:
CGC Stock Symbol:
NYSE Market:
canopygrowth.com Website: